Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
Objective Doxorubicin (Dox) is a frontline chemotherapeutic against osteosarcoma (OS) that is plagued by side effects, particularly in the heart. The specific objective of this article is to investigate whether low-dose Dox treatment had pro-autophagic effects in cardiomyocytes as well as osteosarco...
| Main Authors: | Tacar, O., Indumathy, S., Tan, M., Baindur-Hudson, S., Friedhuber, A., Dass, Crispin |
|---|---|
| Format: | Journal Article |
| Published: |
Blackwell Publishing Ltd
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/11838 |
Similar Items
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)
by: Tan, M., et al.
Published: (2013)
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)
by: Armstrong, J., et al.
Published: (2015)
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)
by: Friedhuber, A., et al.
Published: (2015)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)
by: Tacar, O., et al.
Published: (2013)
Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)
by: Manchun, S., et al.
Published: (2014)
Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)
by: Stanslas, Johnson, et al.
Published: (2022)
Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)
by: Wong, J., et al.
Published: (2016)
Autophagy and cancer: taking the ‘toxic’ out of cytotoxics
by: Giuliani, C., et al.
Published: (2013)
by: Giuliani, C., et al.
Published: (2013)
In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)
Metabolic stress and cancer: is autophagy the common denominator and a feasible target?
by: Giuliani, C., et al.
Published: (2014)
by: Giuliani, C., et al.
Published: (2014)
Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
by: Indumathy, S., et al.
Published: (2013)
by: Indumathy, S., et al.
Published: (2013)
Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010)
by: Broadhead, M., et al.
Published: (2010)
Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)
by: Chandolu, V., et al.
Published: (2012)
The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)
by: Choong, P., et al.
Published: (2011)
Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)
by: Tan, M., et al.
Published: (2010)
The Emerging Role of PEDF in Stem Cell Biology
by: Elahy, Mina, et al.
Published: (2012)
by: Elahy, Mina, et al.
Published: (2012)
Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)
by: Baxter-Holland, M., et al.
Published: (2018)
Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)
by: Manchun, S., et al.
Published: (2016)
Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)
by: Broadhead, M., et al.
Published: (2012)
Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)
by: Cheewatanakornkool, K., et al.
Published: (2017)
Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy
by: Elahy, M., et al.
Published: (2014)
by: Elahy, M., et al.
Published: (2014)
Increased efficacy of biologics following inhibition of autophagy in A549 lung cancer cells in bimodal treatment of doxorubicin and SAR405-loaded chitosan nanoparticles
by: Alamassi, Mohammed Numan, et al.
Published: (2023)
by: Alamassi, Mohammed Numan, et al.
Published: (2023)
Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)
by: Broadhead, M., et al.
Published: (2011)
The Molecular Mechanisms Of Rapamycininduced
Autophagy And Apoptosis In T-47d Breast
Carcinoma Cells
by: Moad, Ahmed Ismail Hassan
Published: (2013)
by: Moad, Ahmed Ismail Hassan
Published: (2013)
Combinatorial application of tocotrienols and chemotherapeutic drugs enhances apoptosis and autophagy in colorectal cancer cells
by: Tham, Shiau Ying
Published: (2020)
by: Tham, Shiau Ying
Published: (2020)
Liver oxidative stress, apoptosis, and autophagy are increased in a mouse model of iron overload
by: Chua, A., et al.
Published: (2017)
by: Chua, A., et al.
Published: (2017)
RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)
by: Akiyama, T., et al.
Published: (2010)
The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)
by: Xiao, S., et al.
Published: (2015)
Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)
by: Manchun, S., et al.
Published: (2015)
Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)
by: Elahy, M., et al.
Published: (2015)
Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)
by: Cheewatanakornkool, K., et al.
Published: (2018)
Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)
by: Ouyang, Z., et al.
Published: (2018)
Assesment On The Cytotoxicity, Apoptosis And Autophagy Properties Of Chemically Synthesised Silver Nanoparticles On Beas 2b Cells
by: Mohd Raflee, Nur Afiqah
Published: (2017)
by: Mohd Raflee, Nur Afiqah
Published: (2017)
The effects of undernutrition and dexamethasone treatment on cultured rat neonatal cardiomyocytes
by: Austin, Ruth Marie
Published: (2010)
by: Austin, Ruth Marie
Published: (2010)
Induction of Caspase-2 Activation by a DNA Enzyme Evokes Tumor Cell Apoptosis
by: Kim, Soo-Hyun, et al.
Published: (2012)
by: Kim, Soo-Hyun, et al.
Published: (2012)
Osteosarcoma: overview, case discussion & Islamic perspective of treatment
by: Sharifudin, Mohd Ariff
Published: (2014)
by: Sharifudin, Mohd Ariff
Published: (2014)
The role of survivin in autophagy
by: Humphry, Nicola
Published: (2018)
by: Humphry, Nicola
Published: (2018)
Autophagy, citrullination and cancer
by: Durrant, LG
Published: (2016)
by: Durrant, LG
Published: (2016)
Similar Items
-
Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013) -
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013) -
Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015) -
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015) -
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)